Sort by
Items per page

Send to

Choose Destination

Best matches for Drugs adrenal insufficiency:

Adrenal insufficiency. Charmandari E et al. Lancet. (2014)

Adrenal insufficiency - recognition and management. Pazderska A et al. Clin Med (Lond). (2017)

[Adrenal Insufficiency]. Burger-Stritt S et al. Dtsch Med Wochenschr. (2016)

Search results

Items: 1 to 20 of 684


Immune-related adverse events following administration of anti-cytotoxic T-lymphocyte-associated protein-4 drugs: a comprehensive systematic review and meta-analysis.

Xu H, Tan P, Zheng X, Huang Y, Lin T, Wei Q, Ai J, Yang L.

Drug Des Devel Ther. 2019 Jul 4;13:2215-2234. doi: 10.2147/DDDT.S196316. eCollection 2019. Review.


Hepatitis B virus reactivation with corticosteroid therapy in patients with adrenal insufficiency.

Hatano M, Mimura T, Shimada A, Noda M, Katayama S.

Endocrinol Diabetes Metab. 2019 May 9;2(3):e00071. doi: 10.1002/edm2.71. eCollection 2019 Jul.


Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark.

Laugesen K, Jorgensen JOL, Petersen I, Sørensen HT.

Eur J Endocrinol. 2019 Jul 1. pii: EJE-19-0305.R1. doi: 10.1530/EJE-19-0305. [Epub ahead of print]


HIV Drug Efavirenz Inhibits CYP21A2 Activity with Possible Clinical Implications.

Malikova J, Zingg T, Fingerhut R, Sluka S, Grössl M, Brixius-Anderko S, Bernhardt R, McDougall J, Pandey AV, Flück CE.

Horm Res Paediatr. 2019 Jun 28:1-9. doi: 10.1159/000500522. [Epub ahead of print]


Management of immune-related adverse events in endocrine organs induced by immune checkpoint inhibitors: clinical guidelines of the Japan Endocrine Society.

Arima H, Iwama S, Inaba H, Ariyasu H, Makita N, Otsuki M, Kageyama K, Imagawa A, Akamizu T.

Endocr J. 2019 Jun 25. doi: 10.1507/endocrj.EJ19-0163. [Epub ahead of print]


Development of geriatric syndromes after taking countermeasures for polypharmacy: an overlooked issue of quitting semiregular single-dose medicine.

Tomita N, Ishiki A, Okinaga S, Furukawa K, Arai H.

Oxf Med Case Reports. 2019 Jun 14;2019(6):omz047. doi: 10.1093/omcr/omz047. eCollection 2019 Jun.


Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents.

Benitez LL, Carver PL.

Drugs. 2019 Jun;79(8):833-853. doi: 10.1007/s40265-019-01127-8. Review.


Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System.

Raschi E, Mazzarella A, Antonazzo IC, Bendinelli N, Forcesi E, Tuccori M, Moretti U, Poluzzi E, De Ponti F.

Target Oncol. 2019 Apr;14(2):205-221. doi: 10.1007/s11523-019-00632-w.


Isolated adrenocorticotropic hormone deficiency and thyroiditis associated with nivolumab therapy in a patient with advanced lung adenocarcinoma: a case report and review of the literature.

Ohara N, Kobayashi M, Ohashi K, Ito R, Ikeda Y, Kawaguchi G, Yoneoka Y, Hasegawa G, Takada T.

J Med Case Rep. 2019 Mar 26;13(1):88. doi: 10.1186/s13256-019-2002-2.


A case of severe rhabdomyolysis associated with secondary adrenal insufficiency and autoimmune hepatitis.

Kennedy L, Nagiah S.

BMJ Case Rep. 2019 Mar 20;12(3). pii: e227343. doi: 10.1136/bcr-2018-227343.


BLT-Immune Humanized Mice as a Model for Nivolumab-Induced Immune-Mediated Adverse Events: Comparison of the NOG and NOG-EXL Strains.

Weaver JL, Zadrozny LM, Gabrielson K, Semple KM, Shea KI, Howard KE.

Toxicol Sci. 2019 May 1;169(1):194-208. doi: 10.1093/toxsci/kfz045.


Iatrogenic adrenal suppression following caudal epidural and facet joint injection.

Jani P, Morley HL, Shetty N.

BMJ Case Rep. 2019 Feb 21;12(2). pii: e225828. doi: 10.1136/bcr-2018-225828.


Addison's Disease Caused by Tuberculosis: Diagnostic and Therapeutic Difficulties.

van Haren Noman S, Visser H, Muller AF, Limonard GJ.

Eur J Case Rep Intern Med. 2018 Aug 28;5(8):000911. doi: 10.12890/2018_000911. eCollection 2018.


PPAR-δ and erucic acid in multiple sclerosis and Alzheimer's Disease. Likely benefits in terms of immunity and metabolism.

Altinoz MA, Ozpinar A.

Int Immunopharmacol. 2019 Apr;69:245-256. doi: 10.1016/j.intimp.2019.01.057. Epub 2019 Feb 8. Review.


Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Tan MH, Iyengar R, Mizokami-Stout K, Yentz S, MacEachern MP, Shen LY, Redman B, Gianchandani R.

Clin Diabetes Endocrinol. 2019 Jan 22;5:1. doi: 10.1186/s40842-018-0073-4. eCollection 2019. Review.


Adverse Event Profiles of Anti-CTLA-4 and Anti-PD-1 Monoclonal Antibodies Alone or in Combination: Analysis of Spontaneous Reports Submitted to FAERS.

Ji HH, Tang XW, Dong Z, Song L, Jia YT.

Clin Drug Investig. 2019 Mar;39(3):319-330. doi: 10.1007/s40261-018-0735-0.


Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study.

Lladó L, González-Castillo A, Fabregat J, Baliellas C, Ramos E, González-Vilatarsana E, Busquets J, Xiol X.

Ann Transplant. 2019 Jan 18;24:36-44. doi: 10.12659/AOT.912444.


Therapy Side Effects in Systemic Lupus Erythematosus.

Popa R, Lautaru LA, Lucretiu R, Ruiu DC, Caragea D, Olteanu M, Mihailovici AR, Ene C, Padureanu V, Padureanu R, Cirlig V.

Curr Health Sci J. 2018 Jul-Sep;44(3):316-321. doi: 10.12865/CHSJ.44.03.18. Epub 2018 Jul 15.


An Update on Addison's Disease.

Barthel A, Benker G, Berens K, Diederich S, Manfras B, Gruber M, Kanczkowski W, Kline G, Kamvissi-Lorenz V, Hahner S, Beuschlein F, Brennand A, Boehm BO, Torpy DJ, Bornstein SR.

Exp Clin Endocrinol Diabetes. 2019 Feb;127(2-03):165-175. doi: 10.1055/a-0804-2715. Epub 2018 Dec 18. Review.


Adverse side effects of dexamethasone in surgical patients.

Polderman JA, Farhang-Razi V, Van Dieren S, Kranke P, DeVries JH, Hollmann MW, Preckel B, Hermanides J.

Cochrane Database Syst Rev. 2018 Nov 23;11:CD011940. doi: 10.1002/14651858.CD011940.pub3.


Supplemental Content

Loading ...
Support Center